Download
1 / 7
70 likes | 73 Views
The global natural killer cells therapeutics market was valued at $1,402 million in 2018, and is projected to reach $5,096 million by 2026, registering a CAGR of 17.4% from 2019 to 2026. Natural killer cells are large granular lymphocytes that respond quickly to a pathological challenge. In addition, they are responsible for producing immunoregulatory cytokines. Moreover, they act as an important component of the innate immune system of a human. The key role of NK cells is to generate an immune response against malignancies and viral infections. <br><br>
E N D
The global natural killer cells therapeutics market was valued at $1,402 million in 2018, and is projected to reach $5,096 million by 2026, registering a CAGR of 17.4% from 2019 to 2026. Natural killer cells are large granular lymphocytes that respond quickly to a pathological challenge. In addition, they are responsible for producing immunoregulatory cytokines. Moreover, they act as an important component of the innate immune system of a human. The key role of NK cells is to generate an immune response against malignancies and viral infections. In the past several years, these cells were being used in various molecular and combinational therapies, which increased the adoption of such treatments. Furthermore, they can be used as an effective therapeutic tool against infectious diseases and as an anti-cancer alternative to T cells. Download Report Sample @ https://www.alliedmarketresearch.com/request-sample/2132 Natural Killer Cells Therapeutics Market Download Report Sample
Rise in adoption of NK cells for the treatment of cancer, infections, and liver diseases is a key factor that drives the growth of the natural killer cells therapeutics market. In addition, NK cells play a pivotal role in tumor immune-surveillance, which boosts the adoption of NK therapeutics across the globe. In addition, rise in awareness among the population regarding various immunotherapies and increase in R&D for the development of bi-specific antibody for engaging NK cells to eliminate tumor cells propel the global market growth. However, lack of specificity and poor in-vivo survival of the cells limit the natural killer cells therapeutics market growth. The global natural killer cells therapeutics market is segmented based on therapeutics, application, end user, and region. Based on therapeutics, the market is classified into NK cell therapies and NK cell directed antibodies. Immunotherapy has emerged as an ideal therapeutic solution to improve the clinical outcome against various malignancies and tumors. Recently, several advances have been made in NK cells therapies such as target recognition, adoptive therapy, and improvement in cellular cytotoxicity. Inquire before buying @ https://www.alliedmarketresearch.com/purchase-enquiry/2132 Natural Killer Cells Therapeutics Market Download Report Sample
NK cell therapeutics involves clinical and experimental research to provide cost-effective treatments with improved success rates. Currently, research is being carried out for adoptive transfer of haploidentical natural killer cells for the consolidated therapy of pediatric acute myeloid leukemia. Thus, NK cell therapeutics have promising applications in various research institutes. The North America natural killer cells therapeutics market share accounted for the highest share in 2018 and is expected to continue its dominance throughout the forecast period. This is attributed to significant increase in prevalence of cancer in this region. However, the Asia-Pacific market is anticipated to grow at the fastest pace, owing to increase in number of patients suffering from cancer, surge in geriatric population, and improvement in healthcare facilities. However, the complexity in regulatory frameworks regarding the approval of immunotherapy is expected to hamper the market growth. Conversely, high incidence of cancer is anticipated to boost the growth of cancer immunotherapy market, which in turn will fuel the growth of the NK cells therapeutics market. Customize request @ https://www.alliedmarketresearch.com/request-for-customization/2132 Natural Killer Cells Therapeutics Market Download Report Sample
The Major Key Players Are: • Affimed N.V. • Celgene Corporation • Fate Therapeutics • Fortress Biotech • Glycostem Therapeutics BV • Innate Pharma S.A. • Nantkwest Inc. • Nkarta Therapeutics, Inc. • NKT Therapeutics Inc. • Ziopharm Oncology Inc. Natural Killer Cells Therapeutics Market Download Report Sample
Key Findings of the Study: • This report entails a detailed quantitative analysis along with the current global market trends from 2019 to 2026 to identify the prevailing opportunities along with the strategic assessment. • The global natural killer cells therapeutics market size and estimations are based on a comprehensive analysis of key developments in the industry. • A qualitative analysis based on innovative products facilitates strategic business planning. • The development strategies adopted by the key market players are enlisted to understand the competitive scenario of the market Natural Killer Cells Therapeutics Market Download Report Sample
Contact: David Correa 5933 NE Win Sivers Drive #205, Portland, OR 97220 United States Toll Free (USA/Canada): +1-800-792-5285, +1-503-894-6022, +1-503-446-1141 UK: +44-845-528-1300 Hong Kong: +852-301-84916 India (Pune): +91-20-66346060 Fax: +1-855-550-5975 help@alliedmarketresearch.com Web: https://www.alliedmarketresearch.com Natural Killer Cells Therapeutics Market Download Report Sample
